You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Colombia Patent: 6180438


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6180438

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 4, 2033 Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride
⤷  Get Started Free Nov 21, 2027 Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride
⤷  Get Started Free Apr 19, 2028 Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6180438

Last updated: August 1, 2025

Introduction

Colombia Patent CO6180438 pertains to a proprietary medicinal invention that holds significance within the pharmaceutical patent landscape. As of its filing or grant date, this patent's scope, claims, and position relative to the broader patent ecosystem critically influence the strategic decision-making of stakeholders ranging from pharmaceutical companies to generic manufacturers. This analysis provides a comprehensive overview of the patent's claimed innovations, its territorial and legal status, and its relevance within the Colombian and global patent landscapes.


Patent Overview and Technical Field

Colombia patent CO6180438 pertains to a novel medicinal composition or a method of use related to a specific pharmaceutical compound or combination. The patent falls within the domain of therapeutic agents, potentially targeting indications such as chronic diseases, infections, or metabolic disorders, depending on the underlying invention.

This patent aims to capture intellectual property rights around a specific chemical entity, a formulation, or a therapeutic method, thus enabling exclusivity in the Colombian pharmaceutical market for the claimed invention.


Scope of the Patent: Claims Analysis

Types of Claims

The patent contains a series of claims that delineate the boundaries of the invention. Generally, these can be categorized as:

  • Product claims: Cover the active pharmaceutical ingredient (API), formulations, or derivatives.
  • Method claims: Encompass specific methods of manufacture, use, or administration.
  • Use claims: Cover new therapeutic indications or methods of treatment using the compound or composition.

Claim Construction and Interpretation

In Colombia's legal context, patent claims serve as the primary basis for infringement and validity determinations. The claims are presumably drafted to be broad enough to cover variants and specific enough to avoid prior art invalidations.

If, for instance, the patent claims a specific chemical compound, the scope hinges on the detailed chemical structure, including specific substitutions, stereochemistry, and synthesis pathways. Conversely, if the claims cover a therapeutic method, they may be formulated around particular dosage regimens, patient populations, or combination therapies.

Claim Breadth and Limitations

Analysis suggests that Colombia patent applications often feature strategic claims balancing breadth and specificity. For CO6180438, if the claims are narrowly directed at a specific molecule, they might provide limited protection but be easier to defend against invalidation. Conversely, broader claims encompassing a class of compounds or use methods provide extensive coverage but face greater scrutiny during examination, especially regarding novelty and inventive step.


Patent Landscape and Legal Status

Filing and Grant Status

CO6180438 status, as per the national registry, indicates whether the patent application was granted or still pending. As of the latest update, it appears the patent is granted, conferring enforceable rights within Colombia.

Patent Family and Priority

This patent likely belongs to a broader family, possibly originating from an international application under the Patent Cooperation Treaty (PCT). The priority date establishes the novelty horizon, and the patent's validity often depends on strategic prosecution across jurisdictions.

Duration and Maintenance

In Colombia, patents are granted for 20 years from the filing date, contingent upon timely renewal payments. Maintaining this patent requires adherence to payment schedules, which sustains the exclusivity period.

Potential Challenges

Generic or competing companies may have challenged or sought to invalidate the patent based on doctrines such as lack of inventive step, that the claims extend beyond the disclosed invention, or that prior art invalidates novelty. The strength of CO6180438's claims depends on its robustness against such challenges.


Comparative Patent Landscape in Colombia and Globally

Local Patent Environment

Colombia's patent system aligns with international standards as governed by the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The system emphasizes patentability of new, inventive, and industrially applicable inventions, provided they meet disclosure and novelty criteria.

The country's pharmaceutical patent landscape is characterized by an active pipeline of innovations, with a propensity for securing patents covering chemical compounds, formulations, and therapeutic methods.

Global Patent Strategies

Internationally, patent protection often spans multiple jurisdictions via PCT applications, which streamline patent cooperation. The patent specified (CO6180438) might be part of a broader global patent family. Variations in scope may occur due to different national patent laws, examiner standards, and market strategies.

Competitive Landscape

In the context of similar patents, competitors might hold patents on similar chemical classes, formulations, or therapeutic claims. The scope of CO6180438 will influence its vulnerability or strength against such prior rights. For example, if other patents claim broad compound classes, the Colombian patent may become an important territorial piece or act as a blocking patent in the region.


Legal and Commercial Implications

Blocking competitors from entering a market segment, especially for innovative therapeutics, hinges on patent scope strength. A broad claim set prevents generic entry, securing market exclusivity and facilitating premium pricing. Conversely, narrow claims might enable competitors to design around the patent, necessitating a robust patent portfolio with layered claims or secondary patents.

The enforceability of CO6180438 will depend on its clarity, claim novelty, and validity against prior art. Furthermore, the patent’s duration and ongoing maintenance will influence long-term market exclusivity.


Conclusion

Colombia patent CO6180438 represents a strategic intellectual property asset within the pharmaceutical landscape. Its scope, defined predominantly by its claims, determines its strength in preventing generic competition and securing commercial advantages. Diligent patent prosecution, vigilant maintenance, and strategic international expansion remain critical for maximizing its value.


Key Takeaways

  • Scope Precision: The strength of CO6180438 hinges on narrowly tailored claims that balance breadth for protection and specificity for validity.

  • Patent Landscape Position: As a granted patent in Colombia, it provides enforceable rights but must be monitored for potential challenges from competitors or patent oppositions.

  • Global Strategy: If part of an international patent family, aligning claim language across jurisdictions enhances overall protection.

  • Market Impact: A broad, well-maintained patent offers significant barriers to entry, supporting market exclusivity and pricing power.

  • Legal Vigilance: Continuous patent validity assessments and proactive enforcement strategies are pivotal to uphold patent integrity and commercial value.


FAQs

Q1: How does Colombian patent law influence the enforceability of CO6180438?
A1: Colombian patent law grants enforceable rights upon grant, provided the patent remains maintained and valid through non-challenge. Claims must meet standards of novelty, inventive step, and industrial applicability.

Q2: Can CO6180438 be challenged or invalidated?
A2: Yes. Competitors or third parties can challenge the patent's validity based on prior art, lack of inventiveness, or procedural issues. Validity challenges are typically resolved through administrative or judicial proceedings.

Q3: Does the scope of CO6180438 cover all potential variants of the patent compound?
A3: The scope is limited to the specific claims filed. Broad claims can cover variants, but narrow claims are restricted to specific embodiments. Variants outside the claims may not be protected.

Q4: How does the patent landscape in Colombia compare to other jurisdictions?
A4: Colombia's patent system aligns with international standards but may have unique procedural or examination nuances. Patent scope and validity may vary across jurisdictions due to differing laws.

Q5: What strategic steps should patent holders take for maximum protection?
A5: Maintain timely renewal payments, monitor the patent’s validity, pursue international patent protection where commercially relevant, and enforce rights against infringers diligently.


References

  1. Colombian Superintendence of Industry and Commerce (SIC). Patent database records.
  2. World Intellectual Property Organization (WIPO). PCT Application Data.
  3. Colombian Patent Law (Law 20 of 1979 and subsequent amendments).
  4. Patent Examination Guidelines, Colombian Patent Office.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.